+86-180-66751838
Tsev / Xov xwm / Ntsiab lus

May 30, 2024

Cov Miraculous Therapeutic Effects Of Luteolin

PCOS yog ib hom kab mob endocrine thiab metabolic cuam tshuam rau 6% txog 10% ntawm cov poj niam uas muaj hnub nyoog me nyuam. Nws feem ntau tshwm sim raws li hyperandrogenism, insulin tsis kam, kev them nyiaj hyperinsulinemia, ovulatory tsis ua haujlwm thiab polycystic zes qe menyuam hloov, ua rau anovulation. Lub ntsiab ua rau kev sib deev infertility. Qhov ua rau PCOS tseem tsis tau paub meej, thiab nws cov kab mob pathophysiology thiab cov txheej txheem sab hauv yog qhov nyuaj.

Tam sim no, kev kho mob rau PCOS feem ntau tsom rau kev tswj cov tsos mob es tsis yog kho tus kab mob nws tus kheej. Txoj kev kho mob txawv raws li tus neeg mob xav tau thiab tej yam kev mob tshwj xeeb, thiab feem ntau yog tsom rau kev kho cov tsos mob thiab daws teeb meem fertility. Piv txwv li, aromatase inhibitor letrozole txhawb ovulation tab sis tsis muaj kev cuam tshuam rau cov tshuaj insulin siab. Yog li, tsim cov tswv yim kho tshiab yuav ua rau muaj txiaj ntsig zoo dua thiab muaj kev phiv tsawg dua rau cov neeg mob PCOS.

news-393-278

Motherwort tau ntev tau siv dav hauv Suav teb thiab lwm lub tebchaws Esxias los daws cov kab mob gynecological yam ntxwv los ntawm estrogen imbalance. Raws li ib qho ntawm feem ntau siv tshuaj ntsuab rau kev kho mob ntawm PCOS, cov kev tshawb fawb tau ua pov thawj tias nws tuaj yeem txhim kho tus nqi kho tau zoo, txhim kho cov ntshav qab zib thiab lwm yam cuam tshuam, thiab ua rau muaj kev cuam tshuam tsawg dua hauv PCOS cov neeg mob kho nrog clomiphene. Txawm li cas los xij, cov tshuaj muaj pes tsawg leeg thiab cov txheej txheem hauv qab uas cov nroj tsuag tshuaj ntsuab no qhia txog cov txiaj ntsig zoo ntawm cov kab mob gynecological tsis nkag siab tag nrho.

Pab neeg tshawb fawb pom los ntawm kev tshawb fawb tias luteolin thiab nws cov analogue luteolin -7-methyl ether hauv motherwort tuaj yeem cuam tshuam biosynthesis ntawm estrogen induced los ntawm follicle-stimulating hormone (FSH) hauv tib neeg zes qe menyuam granulosa hlwb. Qhov no Cov txiaj ntsig tau ua tiav los ntawm kev txo qis cov lus qhia ntawm aromatase kho los ntawm cAMP cov lus teb cov ntsiab lus binding protein (CREB).

Txoj kev tshawb no kuj pom thawj zaug uas qog nqaij hlav loj hlob locus 2 (TPL2) koom nrog hauv kev tswj cov tshuaj estrogen biosynthesis mediated los ntawm aromatase, thiab luteolin thiab luteolin -7-methyl ether ncaj qha ua rau cov hlwb TPL2 inhibits mitogen-activated protein kinase kinase 3. /6 (MKK3/6)-p38 MAPK-CREB txoj kev taw qhia, yog li txo cov aromatase qhia thiab estrogen biosynthesis hauv zes qe menyuam granulosa hlwb.

Tsis tas li ntawd, luteolin thiab luteolin -7-methyl ether tuaj yeem txo cov tsos mob ntawm PCOS nas, txo cov theem androgen, txo cov cystic follicles, txo cov qib insulin thiab txhawb ovulation. Cov kev tshawb pom no qhia tias luteolin thiab luteolin-7-methyl ether muaj peev xwm los ua cov tshuaj kho tshiab rau kev kho PCOS.

Xa lus